Target intelligence / Profile preview

Caveolin-1 mRNA (CAV1 mRNA)

Target
CAV1 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Caveolin-1 (CAV1) mRNA is the transcript of the CAV1 gene, which encodes the primary structural protein of caveolae, specialized omega-shaped invaginations of the plasma membrane. These structures serve as essential hubs for organizing signaling complexes, regulating cholesterol transport, and mediating endocytosis. CAV1 mRNA expression is highly dynamic and context-specific; it often acts as a tumor suppressor in early-stage cancers but is frequently upregulated in advanced metastatic and multidrug-resistant tumors. Furthermore, its downregulation is a hallmark of various fibrotic diseases, including pulmonary and renal fibrosis. Therapeutic targeting of CAV1 mRNA primarily involves the use of small interfering RNAs (siRNAs) or antisense oligonucleotides (ASOs) to silence its expression in overexpressing disease states like certain cancers. Conversely, research into stabilizing or upregulating CAV1 mRNA is being explored for conditions where its loss contributes to pathogenesis, such as in metabolic disorders and fibrosis.

Other names
Caveolin 1 messenger RNAVIP21 mRNABSCL3 mRNACGL3 mRNALCCNS mRNAMSTP085 mRNAPPH3 mRNA
02

Mechanism of action

RNA interference (RNAi) mediated by siRNA or antisense inhibition via oligonucleotides leads to sequence-specific mRNA degradation or translation blockade, thereby reducing Caveolin-1 protein levels.

03

Biological functions

Template for protein synthesisRegulation of caveolae formationSignal transduction regulationCholesterol homeostasisEndocytosisVesicular transportCell cycle regulationApoptosis regulation
04

Disease associations

CancerFibrosisCardiovascular diseaseMetabolic syndromeDiabetesAlzheimer's diseaseLipodystrophy
05

Safety considerations

Off-target effects of oligonucleotidesDelivery challenges to extrahepatic tissuesContext-dependent role in cancer (tumor suppressor vs. promoter)Potential disruption of systemic cholesterol homeostasis
06

Interacting drugs

CAV1 siRNA (experimental)

4 more in the full profile.

07

Biomarkers

CAV1 mRNA expression levelCaveolin-1 protein level (IHC)Serum Caveolin-1 level

Beyond the preview

Go deeper on Caveolin-1 mRNA (CAV1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caveolin-1 mRNA (CAV1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call